Pharma Journalist -

GSK and Medicines for Malaria Venture (MMV) announced that the Australian Therapeutic Goods Administration (TGA) accepted the submission of a Category 1 application to extend the…
Read More...

SMi Reports: 8th annual Pre-Filled Syringes East Coast virtual conference taking place on 26th and 27th April 2021. Pre-Filled Syringes East Coast 2021 for your chance to network…
Read More...

SMi Reports: Exploring the challenges, practices and drivers in the aftermath of the transition for Parallel Trade As part of the 15th annual Parallel Trade conference. The two-day…
Read More...

Humanigen, Inc. (HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm with its lead drug…
Read More...

Celularity Inc. and GX Acquisition Corp announced they have entered into a definitive merger agreement pursuant to which GX Acquisition Corp. will combine with Celularity. Upon the…
Read More...

Affinivax, Inc. a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS (Multiple Antigen Presenting System) platform, announced…
Read More...

Teva Pharmaceuticals Industries Ltd. and MedinCell announced positive results for study TV46000-CNS-30072 (the RISE study – The Risperidone Subcutaneous Extended-Release Study), a Phase…
Read More...

Pfizer Inc. announced that the first participant has been dosed in the Phase 3 CIFFREO study, which will evaluate the efficacy and safety of investigational gene therapy candidate…
Read More...

BlueRock Therapeutics, a preclinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, in collaboration with Memorial Sloan Kettering Cancer Center (MSK),…
Read More...

Bayer has signed a collaboration and services agreement with CureVac N.V. a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic…
Read More...